Rick Doblin

Impolitic with John Heilemann

Audacy | Puck

News, Politics

4.8 • 4.5K Ratings

🗓️ 1 June 2021

⏱️ ? minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

In which John Heilemann talks with Rick Doblin, the pioneering champion of psychedelics who has waged a decades-long crusade to bring about mainstream acceptance of psychoactive drugs for therapeutic and recreational use. Heilemann and Doblin have known each other for more than 30 years, and they discuss Doblin’s path-breaking work at the Multidisciplinary Association for Psychedelic Studies, which he founded and has turned into a multimillion dollar research and advocacy group employing 130 neuroscientists, pharmacologists, and regulatory specialists; his focus on paving the way for MDMA (aka Ecstasy or Molly) to be used in clinical settings as a treatment for depression, addiction, PTSD, and other maladies; how the cultural acceptance of marijuana (first as a medicine and then more broadly) is a leading indicator of where things are headed with MDMA, psilocybin mushrooms, LSD, and other mind-altering compounds; the future of psychedelic medicine, now that FDA approval is on the horizon; and the coming psychedelics investment bubble. Doblin also describes his personal experiences with psychedelics and how they changed his life, as well as the potential for backlash to the psychedelic renaissance, especially from fundamentalist groups, as social mores change. Hosted on Acast. See acast.com/privacy for more information. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0	Hey everyone, John Hyalman here and welcome to Hell in High Water, my podcast from the
0:18.5	recount and I heart radio with big ups to the one and only Rizza for our dope theme music.
0:23.2	A few weeks ago, a story appeared in the New York Times that caught a lot of people's attention,
0:27.5	most definitely including mine, the headline of the piece was, quote,
0:31.4	the psychedelic revolution is coming, psychiatry may never be the same.
0:35.4	The subhead was, quote,
0:37.5	psilocybin and MDMA are poised to be the hottest new therapeutics since Prozac.
0:43.8	These were dramatic head-turning claims and for those of us who have been following the story for decades,
0:49.6	they marked a moment in history that a lot of us believed for a long time would never arrive.
0:53.9	As soon as I saw the headline and the subhead, I thought of a guy that I've known since 1988,
0:58.4	guy who believed all along at this moment in fact would come, who's devoted much of his adult
1:03.7	life to making sure it did, and who can now claim, I think fairly, now claim credit,
1:10.6	as the single person who's done more than anyone on the planet,
1:13.3	doshering in a change that some of us believe is a huge piece of therapeutic, social and political progress.
1:19.4	At that point, I started to read the body of the article in the Times, and there, right in the first sentence,
1:25.3	immediately following a somewhat predictable hat tip to the grateful dead,
1:28.9	was the very guy that I was thinking of.
1:31.2	Here's how that story started, quote,
1:32.9	it's been a long, strange trip, in the four decades since Rick Doblin, a pioneering psychedelic researcher,
1:39.8	dropped his first hit of acid in college and decided to dedicate his life to the healing powers
1:44.5	of mind-altering compounds.
1:46.4	If you haven't read the story in the Times yet, I suggest you do.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Audacy | Puck, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Audacy | Puck and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.